This week in stem cells
On Nature Reports Stem Cells and Nature News
News
Ethics scrutiny needed for Chinese-European projects
Panel calls for joint advisory body to monitor research.
Stem-cell drug fails crucial trials
Experimental treatment does not halt fatal complication of bone-marrow transplant.
Stem cell company accused of hype
Strong words from the SEC
News and highlights from recently published papers
International Stem Cell Research Society reading list, a compilation of papers presented at ISSCR
Induced pluripotent stem cells down to one factor
Human neural stem cells reprogrammed with only OCT4
What does Nanog do?
In embryos and induced pluripotent stem cells, Nanog sets the ground state of pluripotency
Stem cells delay disease onset in mice with neurodegenerative disease
Transplanted cells from biotech company detoxify poisoned brains, at least for awhile
Research papers and perspectives
A luminal epithelial stem cell that is a cell of origin for prostate cancer from Michael Shen at Columbia University and colleagues
The story was reported, among other places, in Reuters. Here’s the press release.
Developmental biology: Instructions writ in blood by Tariq Enver and Sten Jacobsen at University of Oxford
Cancer stem cells: mirage or reality? by Robert Weinberg at the Broad Institute and colleagues
Systems biology of stem cell fate and cellular reprogramming by Ihor Lemischka and colleagues at Mount Sinai School of Medicine
